Blog
New research, regulatory news and lab questions about research peptides, three times a week. Every post cites its sources and links to the full reference entries. RSS feed.
HHS lets pharmacies compound BPC-157 and five other peptides: what the October 2026 policy does and doesn't do
An interim HHS policy filed October 28 pauses enforcement against 503A pharmacies compounding BPC-157, TB-500, KPV, MOTS-c, semax and epitalon under strict conditions. It is not an approval, and it does not cover research-use-only material.